Epidemiology of organic solvents and connective tissue disease
Tóm tắt
Case reports suggest that solvents are associated with various connective tissue diseases (systemic sclerosis, scleroderma, undifferentiated connective tissue disease, systemic lupus erythematosis, and rheumatoid arthritis), particularly systemic sclerosis. A small number of epidemiological studies have shown statistically significant but weak associations between solvent exposure, systemic sclerosis, and undifferentiated connective tissue disease. However, the interpretation of these positive findings is tempered by a lack of replication, an inability to specify which solvents convey risk, and an absence of increasing risk with increasing exposure. Existing studies, on aggregate, do not show conclusively that solvents (either as a group of chemicals or individual chemicals) are causally associated with any connective tissue disease. Further investigations should be carried out to replicate the positive existing findings and to specify the solvents and circumstances of exposure that carry risk.
Tài liệu tham khảo
Reinl W: Scleroderma caused by trichloroethylene in workers [in German]. Bull Hyg. 1957, 32: 678-
Walder BK: Solvents and scleroderma [letter]. Lancet . 1965, ii: 436-
American Mutual Insurance Alliance : . Handbook of Organic Industrial Solvents. Chicago, IL: American Mutual Insurance Alliance. 1972
American Society for Testing and Materials : . Cold Cleaning with Halogenated Solvents. Philadelphia, PA: American Society for Testing and Materials. 1981
Silman AJ: Epidemiology of scleroderma. Ann Rheum Dis . 1991, 50: 846-853.
Medsger TA, Masi AT: The epidemiology of systematic sclerosis (scleroderma) among male US veterans. J Chron Dis. 1978, 31: 73-85.
Medsger TA, Masi AT: Epidemiology of systematic sclerosis (scleroderma). Ann Intern Med. 1971, 74: 714-721.
Englert H, Small-McMahon J, Chambers P: Familial risk estimation in systemic sclerosis. Aust N Z J Med. 1999, 29: 36-41.
Tan FK, Stivers DN, Foster MW: Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a native american population. Arthritis Rheum. 1998, 41: 1729-1737.
Tan FK, Stivers DN, Arnett FC: HLA Haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a native american population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens. 1999, 53: 74-80. 10.1034/j.1399-0039.1999.530108.x.
Fanning GC, Welsh KI, Bunn C, DuBois R, Black CM: HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol. 1998, 37: 201-207.
Kuwana M, Inoko H, Kameda H: Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in japanese patients with systemic sclerosis. Intern Med. 1999, 38: 336-344.
Frank KH, Fussel M, Conrad K: Different distribution of HLA class II and tumor necrosis factor alleles (TNF-308.2, TNFa2 microsatellite) in anti-topomerase I responders among scleroderma patients with and without exposure to quartz/metal dust. Arthritis Rheum. 1998, 41: 1306-1311.
Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W: Scleroderma and occupational exposure. Scand J Work Environ Health. 1995, 21: 289-292.
Cowie RL: Silica-dust-exposed mine workers with scleroderma (systemic sclerosis). Chest. 1987, 92: 260-262.
Haustein U-F, Ziegler V, Herrmann K, Mehlhorn J, Schmidt C: Silica-induced scleroderma. J Am Acad Dermatol. 1990, 22: 444-448.
McHugh NJ, Whyte J, Harvey G, Haustein UF: Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. Arthritis Rheum. 1994, 37: 1198-1205.
Pelmear PL, Roos JO, Maehle WM: Occupationally-induced scleroderma. J Occup Med. 1992, 34: 20-25.
Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA: Silica, silicosis, and progressive systemic sclerosis. Br J Indust Med. 1985, 42: 838-843.
Steenland K, Goldsmith DF: Silica exposure and autoimmune diseases. Am J Indust Med. 1995, 28: 603-608.
Black CM, Walker AE, Catoggio LJ: Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet. 1983, 1: 53-55.
Bretza J, Goldman JA: Scleroderma simulating vinyl chloride disease. J Occup Med. 1979, 21: 436-438.
Haustein UF, Ziegler V: Environmentally induced systemic sclerosis-like disorders. Int J Dermatol. 1985, 24: 147-151.
Silman AJ, Hochberg MC: Occupational and environmental influences on scleroderma. Rheum Dis Clin N Am. 1996, 22: 737-749.
Haustein U-F, Herrmann K: Environmental scleroderma. Clin Dermatol. 1994, 12: 467-473.
Walder BK: Do solvents cause scleroderma?. Int J Dermatol. 1983, 22: 157-158.
Zachariae H, Bjerring P, Sondergaard KH, Halkier-Sorensen L: Occupational systemic sclerosis in men [in Danish]. Ugeskr Laeger. 1997, 159: 2687-2689.
Garcia-Zamalloa AM, Ojeda E, Gonzalez-Beneitez C, Goni J, Garrido A: Systemic sclerosis and organic solvents: early diagnosis in industry [letter]. Ann Rheum Dis. 1994, 53: 618-
Czirjak L, Schlammadinger J, Szegedi G: Systemic sclerosis and exposure to trichloroethylene [letter]. Dermatology. 1993, 186: 236-237.
Lockey JE, Kelly CR, Cannon GW: Progressive systemic sclerosis associated with exposure to trichloroethylene. J Occup Med. 1987, 29: 493-496.
Flindt-Hansen H, Isager H: Scleroderma after occupational exposure to trichloroethylene and trichloroethane. Acta Derm Venereol. 1995, 67: 263-264.
Tibon-Fisher O: Occupational scleroderma due to organic exposure. Harefuah. 1992, 122: 530-532.
Czirjak L, Szegedi G: Benzene exposure and systemic sclerosis. Ann Intern Med. 1987, 107: 118-
Yanez-Diaz S, Moran M, Unamuno P, Armijo M: Silica and trichloroethylene-induced progressive systemic sclerosis. Dermatology. 1992, 184: 98-102.
Czirjak L, Pocs E, Szegedi G: Localized scleroderma after exposure to organic solvents. Dermatology. 1994, 189: 399-401.
Hinnen U, Schmid-Grendelmeier P, Muller E, Elsner P: Solvent exposure in scleroderma: disseminated circumscribed scleroderma (morphea) in a painter exposed to perchloroethylene [in German]. Schweiz Med Wschr. 1995, 125: 2433-2437.
Yamakage A, Ishikawa H: Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica. 1982, 165: 186-193.
Nietert PJ, Sutherland SE, Silver RM: Is occupational organic solvent exposure a risk factor for scleroderma? . Arthritis Rheum. 1998, 41: 1111-1118.
Silman AJ, Jones S: What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?. Ann Rheum Dis. 1992, 51: 1322-1324.
Goldman JA: Connective tissue disease in people exposed to organic chemical solvents. Systemic sclerosis (scleroderma) in dry cleaning and aircraft industry workers. J Clin Rheumatol. 1996, 2: 185-190.
Betta A, Tommasini M, Bovenzi M, Barbone F: Occupational factors for scleroderma: case-control study with literature review [in Italian]. Med Lavoro. 1994, 85: 496-506.
Czirjak L, Bokk A, Csontos G: Clinical findings in sixty one patients with progressive systemic sclerosis. Acta Derm Venereol . 1989, 69: 533-536.
Lundberg I, Alfredsson L, Plato N: Occupation, occupational exposures to chemicals and rheumatological disease: a register based cohort study. Scand J Rheumatol. 1994, 23: 305-310.
Svensson BG, Nise G, Englander V: Deaths and tumours among rotogravure printers exposed to toluene. Br J Indust Med. 1990, 47: 372-379.
Michaels D, Zoloth SR, Stern FB: Does low-level lead exposure increase risk of death? A mortality study of newspaper printers. Int J Epidemiol. 1991, 20: 978-983.
Leon DA, Thomas P, Hutchings S: Lung cancer among newspaper printers exposed to ink mist: a study of trade union members in Manchester, England. Occup Environ Med. 1994, 51: 87-94.
Brown DP, Kaplan SD: Retrospective cohort mortality study of dry cleaner workers using perchloroethylene. J Occup Med. 1987, 29: 535-542.
Duh RW, Asal NR: Mortality among laundry and dry cleaning workers in Oklahoma. Am J Public Health. 1984, 74: 1278-1280.
Katz RM, Jowett D: Female laundry and dry cleaning workers in Wisconsin: a mortality analysis. Am J Public Health. 1981, 71: 305-307.
Ruder AM, Ward EM, Brown DP: Cancer mortality in female and male dry-cleaning workers. J Occup Med. 1994, 36: 867-874.
Bertazzi PA, Pesatori AC, Zocchetti C, Latocca R: Mortality study of cancer risk among oil refinery workers. Int Arch Occup Environ Health. 1989, 61: 261-270.
Collingwood KW, Raabe GK, Wong O: An updated cohort mortality study of workers at a northwestern United States petroleum refinery. Int Arch Occup Environ Health. 1996, 68: 277-288. 10.1007/s004200050062.
Consonni D, Pesatori AC, Tironi A, Bernucci I: Mortality study in an Italian oil refinery: extension of the follow-up. Am J Indust Med. 1999, 35: 287-294.
Dagg TG, Satin KP, Bailey WJ: An updated cause specific mortality study of petroleum refinery workers. Br J Indust Med. 1992, 49: 203-212.
Divine BJ, Barron V, Kaplan SD: Texaco mortality study. J Occup Med. 1985, 27: 445-447.
Divine BJ, Barron V: Texaco mortality study: a cohort study of producing and pipeline workers. Am J Indust Med. 1987, 11: 189-202.
Hanis NM, Shallenberger LG, Donaleski DL, Sales EA: A retrospective mortality study of workers in three major US refineries and chemical plants. Part II: internal comparisons by geographic site, occupation, and smoking history. J Occup Med. 1985, 27: 361-369.
Honda Y, Delzell E, Cole P: An updated study of mortality among workers at a petroleum manufacturing plant. J Occup Environ Med. 1995, 37: 194-200.
Kaplan SD: Update of a mortality study of workers in petroleum refineries. J Occup Med. 1986, 28: 514-516.
Marsh GM, Enterline PE, McCraw D: Mortality patterns among petroleum refinery and chemical plant workers. Am J Indust Med. 1991, 19: 29-42.
Satin KP, Wong O, Yuan LA: A 50-year mortality follow-up of a large cohort of oil refinery workers in Texas. J Occup Environ Med. 1996, 38: 492-506.
Schnatter AR, Theriault GP, Katz AM: A retrospective mortality study within operating segments of a petroleum company. Am J Indust Med. 1992, 22: 209-229.
Schnatter AR, Katz AM, Nicolich MJ, Theriault GP: A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect. 1993, 101 (suppl 6): 85-99.
Shallenberger LG, Acquavella JF, Donaleski D: An updated mortality study of workers in three major United States refineries and chemical plants. Br J Indust Med. 1992, 49: 345-354.
Tsai SP, Gilstrap EL, Colangelo TA, Menard AK, Ross CE: A mortality study of oil refinery and petrochemical employees. J Occup Environ Med. 1997, 39: 448-454.
Wen CP, Tsai SP, McClellan WA, Gibson RL: Long-term mortality study of oil refinery workers. Am J Epidemiol. 1983, 118: 526-542.
Wen CP, Tsai SP, Gibson RL, McClellan WA: Long-term mortality of oil refinery workers. II. Comparison of the experience of active, terminated and retired workers. J Occup Med. 1984, 26: 118-127.
Wong O, Morgan RW, Bailey WJ: An epidemiological study of petroleum refinery workers. Br J Indust Med. 1986, 43: 6-17.
Wong O, Harris F, Smith TJ: Health effects of gasoline exposure. Mortality patterns of distribution workers in the United States. Environ Health Perspect. 1993, 101 (suppl 6): 63-76.
Wong O: An industry wide mortality study of chemical workers occupationally exposed to benzene — I. General results. Br JIndust Med. 1987, 44: 365-381.
Tsai SP, Wen CP, Weiss NS: Retrospective mortality and medical surveillance studies of workers in benzene areas of refineries. J Occup Med. 1983, 25: 685-692.
Greene MH, Hoover RN, Eck RL, Fraumeni JF: Cancer mortality among printing plant workers. Environ Res. 1979, 20: 66-73.
Morgan RW, Claxton KW, Kaplan SD, Parsons JM, Wong O: Mortality of paint and coatings industry workers. J Occup Med. 1985, 27: 377-378.
Matanoski GM, Stockwell HG, Diamond EL: A cohort mortality study of painters and allied tradesmen. Scand J Work Environ Health. 1986, 12: 6-21.
Park R, Krebs J, Mirer F: Mortality at an automotive stamping and assembly complex. Am J Indust Med. 1994, 26: 449-463.
Bottomley WW, Sheehan-Dare RA, Hughes P, Cunliffe WJ: A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol. 1993, 128: 203-206.
Sparrow GP: A connective tissue disorder similar to vinyl chloride disease in a patient exposed to perchloroethylene. Clin Exp Dermatol. 1977, 2: 17-22.
Altomonte A, Zoli A, Galossi A, Mancusa L: Scleroderma-like disease following occupational exposure to organic solvents. Clin Rheumatol. 1996, 15: 416-417.
Saihan EM, Burton JL, Heaton KW: A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropathy. Br J Dermatol. 1978, 99: 437-440.
Lacey JV, Garabrant DH, Laing TJ: Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol. 1999, 149: 761-770.
Omdal R, Olsen H, Berge SR, Stabell KE: Do exposure to organic solvents precipitate rheumatic disease?. Clin Rheumatol. 1986, 5: 421-422.
International Agency for Research on Cancer : Occupational exposures in petroleum refining; crude oil and major petroleum fuels. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 45. Lyon, France: International Agency for Research on Cancer. 1989, 5-322.
International Agency for Research on Cancer : Some organic solvents, resin monomers and related compounds, pigments and occupational exposures in paint manufacture and painting. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 47. Lyon, France: International Agency for Research on Cancer,. 1989, 7-535.
International Agency for Research on Cancer : Dry cleaning, some chlorinated solvents and other industrial chemicals. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 63. Lyon: International Agency for Research on Cancer,. 1995, 33-71.
Agency for Toxic Substances and Disease Registry : . Toxicology Profile for Trichloroethylene (update). Washington, DC: Agency for Toxic Substances and Disease Registry, US DHHS,. 1997, 1-298.